Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-113082
Filing Date
2009-05-15
Accepted
2009-05-15 16:07:45
Documents
22
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 893964
2 LICENSE AND SUBLICENSE AGREEMENT, DATED OCTOBER 28, 2003 dex101.htm EX-10.1 106977
3 AMENDMENT TO LICENSE AND SUBLICENSE AGREEMENT, DATED FEBRUARY 22, 2006 dex102.htm EX-10.2 26529
4 EXCLUSIVE LICENSE AGREEMENT, DATED OCTOBER 14, 2005 dex103.htm EX-10.3 133194
5 FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT, DATED JUNE 23, 2006 dex104.htm EX-10.4 16246
6 SECOND AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT, DATED JULY 20, 2006 dex105.htm EX-10.5 18490
7 THIRD AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT, DATED JULY 19, 2007 dex106.htm EX-10.6 9814
8 FOURTH AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT, DATED AUGUST 22, 2007 dex107.htm EX-10.7 15803
9 DIAGNOSTIC, COLLABORATION AND OPTION AGREEMENT, DATED JUNE 23, 2006 dex108.htm EX-10.8 80212
10 AMENDMENT TO DIAGNOSTIC, COLLABORATION AND OPTION AGREEMENT dex109.htm EX-10.9 10806
11 MANUFACTURING AGREEMENT, DATED SEPTEMBER 11, 2006 dex1010.htm EX-10.10 317321
12 DEVELOPMENT, COMMERCIALIZATION AND LICENSING AGREEMENT, DATED FEBURARY 1, 2007 dex1011.htm EX-10.11 133625
13 AMENDMENT NO. 1 TO DEVELOPMENT, COMMERCIALIZATION AND LICENSING AGREEMENT dex1012.htm EX-10.12 6814
14 AMENDMENT NO. 2 TO DEVELOPMENT, COMMERCIALIZATION AND LICENSING AGREEMENT dex1013.htm EX-10.13 16556
15 UNRESTRICTED RESEARCH GRANT WITH THE UNIVERSITY OF COLORADO, DATED JULY 27, 2007 dex1014.htm EX-10.14 9231
16 UNRESTRICTED RESEARCH GRANT WITH THE UNIVERSITY OF COLORADO dex1015.htm EX-10.15 9101
17 MATERIALS TRANSFER AGREEMENT, DATED OCTOBER 14, 2005 dex1016.htm EX-10.16 25741
18 CERTIFICATION OF THE CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 5722
19 CERTIFICATION OF THE CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 5826
20 CERTIFICATION OF THE CEO AND CFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 5033
21 GRAPHIC g95084g06b45.jpg GRAPHIC 5211
22 GRAPHIC g95084g18o55.jpg GRAPHIC 6090
  Complete submission text file 0001193125-09-113082.txt   1864483
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 09833046
SIC: 2835 In Vitro & In Vivo Diagnostic Substances